Anti-Human F10 & F9 activated form Recombinant Antibody

Name: Anti-Human F10 & F9 activated form Recombinant Antibody
Brand: KMD Bioscience
SKU: YR1383

YR1383

科研级 Emicizumab ( 依米赛珠单抗 ), Anti-F10 & F9 activated form Recombinant Antibody, Research Grade Emicizumab

DATASHEET MSDS

Product Description

Alias	科研级 Emicizumab ( 依米赛珠单抗 ), Anti-F10 & F9 activated form Recombinant Antibody, Research Grade Emicizumab
Catalog Number	YR1383
Molecular Name	Emicizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG4 Kappa
Formulation	PBS, pH7.5
Background	Emicizumab (trade name Hemlibra) is a humanized bispecific antibody for the treatment of haemophilia A, developed by Genentech and Chugai (a subsidiary of Roche). A Phase I clinical trial found that it was well tolerated by healthy subjects.
CAS Number	1610943-06-0
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	F10 & F9 activated form[Homo sapiens]

Login